LS 2

梁 珊珊(Shanshan Liang)

特別協力研究員

大連大学付属中山病院

腫瘍学分子病理診断研究室 助理研究員

[専門] 腫瘍学

論文

  1. Liang S, Takahashi H, Hirose T, Kuramitsu Y, Hatakeyama S, Wang R, Yoshiyama H, Hamada J, Iizasa H. NONO is a negative regulator of SOX2 promoter. Cancer Genom Proteom 17(4):359-367 (2020). doi: 10.21873/cgp.20195. New!!
  2. Sakata K, Maeda K, Sakurai N, Liang S, Nakazawa S, Yanagihara K, Kubo T, Yoshiyama H, Kitagawa Y, Hamada J*, Iizasa H*. ADAR2 regulates malignant behavior in mesothelioma cell lines independent of RNA-editing activity. Anticancer Res. 40(3):1307-1314 (2020). doi:10.21873/anticancers.14072. (*Corresponding author) New!!
  3. Liu M, Wang R, Sun X, Liu Y, Wang Z, Yan J, Kong X, Liang S, Liu Q, Zhao T, Ji X, Wang G, Lv W, Li H, Sun M. Prognostic significance of PD-L1 expression on cell-surface vimentin-positive circulating tumor cells in gastric cancer patients. Mol Oncol  doi: 10.1002/1878-0261.12643.
  4. Wang Z, Liu G, Mao J, Xie M, Zhao M, Guo X, Liang S, Li H, Li X, Wang R. IGF-1R inhibition suppresses cell proliferation and increases radiosensitivity in nasopharyngeal carcinoma cells. Mediat Inflamm 2019:1-9 (2019). doi: 10.1155/2019/5497467. 
  5. Nakazawa S, Sakata KI, Liang S, Yoshikawa K, Iizasa H, Tada M, Hamada JI, Kashiwazaki H, Kitagawa Y, Yamazaki Y. Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. Biomed Res 40(1):37-49 (2019). doi: 10.2220/biomedres.40.37. 
  6. Wang R, Li H, Guo X, Wang Z, Liang S, Dang C. IGF-I Induces Epithelial-to-Mesenchymal Transition via the IGF-IR-Src-MicroRNA-30a-E-Cadherin Pathway in Nasopharyngeal Carcinoma Cells. Oncol Res. 24(4):225-231 (2016). doi: 10.3727/096504016X14648701447931.
  7. Li H, Zhao T, Ji X, Liang S, Wang Z, Yang Y, Yin J, Wang R.Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.Tumour Biol 37(3):3535-3542 (2016). doi: 10.1007/s13277-015-4184-6.
  8. Goudarzi H, Iizasa H, Furuhashi M, Nakazawa S, Nakane R, Liang S, Hida Y, Yanagihara K, Kubo T, Nakagawa K, Kobayashi, M, Irimura T, Hamada J. Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway. Cancer Lett 339 (1) : 82-92 (2013).
  9. Liang S, Furuhashi M, Nakane R, Nakazawa S, Goudarzi H, Hamada J, Iizasa H*. Isolation and characterization of human breast cancer cells with SOX2 promoter activity. Biochem Biophys Res Commun 437 (2) : 205-211 (2013).

受賞歴等

  1. 公益信託岩澤ゑい癌研究助成基金(2014)
  2. 第4回北海道大学遺伝子病制御研究所(IGM)リサーチワークショップ(IGM研究交流会)ポスター部門3位(2013)